11/25
04:04 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 21 Filed by: Blume-Jensen Peter
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 21 Filed by: Blume-Jensen Peter
11/21
05:37 pm
acrv
Form SCHEDULE 13G Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
Low
Report
Form SCHEDULE 13G Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
11/18
04:34 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Peterson Katharine
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Peterson Katharine
11/18
04:32 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Miller Mary
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Miller Mary
11/18
04:31 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Gamelin Erick
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Gamelin Erick
11/18
04:30 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Devroe Eric
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Devroe Eric
11/18
04:29 pm
acrv
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Blume-Jensen Peter
Low
Report
Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Blume-Jensen Peter
11/14
04:10 pm
acrv
Form SCHEDULE 13G/A Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A Acrivon Therapeutics, Filed by: CITADEL ADVISORS LLC
10/21
04:07 pm
acrv
Form 4 Acrivon Therapeutics, For: Oct 17 Filed by: Miller Mary
Low
Report
Form 4 Acrivon Therapeutics, For: Oct 17 Filed by: Miller Mary
10/3
04:28 pm
acrv
Form 4 Acrivon Therapeutics, For: Oct 01 Filed by: Mirza Mansoor Raza
Neutral
Report
Form 4 Acrivon Therapeutics, For: Oct 01 Filed by: Mirza Mansoor Raza
10/3
04:26 pm
acrv
Form 4 Acrivon Therapeutics, For: Oct 01 Filed by: Miller Mary
Neutral
Report
Form 4 Acrivon Therapeutics, For: Oct 01 Filed by: Miller Mary
9/5
04:26 pm
acrv
Form 8-K Acrivon Therapeutics, For: Sep 05
High
Report
Form 8-K Acrivon Therapeutics, For: Sep 05